EUVIMEDEUVIMED entdecken
MetaanalyseLeserbriefOpen Access · CC BY 4.0

Impact of Monacolin K‐Containing Supplements on Lipid Profile: A Meta‐Analysis of Randomised Controlled Trials

Tannaz Jamialahmadi iD, Elaheh Mirhadi, Sercan Karav iD, Prashant Kesharwani iD, Amirhossein Sahebkar iD

Endocrinology, Diabetes & Metabolism · 2026

DOI: 10.1002/edm2.70166 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2026. Verfasst von Tannaz Jamialahmadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Dietary Supplements, Lovastatin, Lipids, Hypercholesterolemia. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Natural products have gained attention as alternative strategies for managing dyslipidemia, particularly in individuals who are resistant or unwilling to use conventional pharmacotherapies. Monacolin K, a compound derived from natural sources, has demonstrated potential benefits in improving lipid profile indices across various doses and supplementation durations. This study aimed to quantitatively evaluate the effects of monacolin K‐containing products on plasma lipid levels through a meta‐analysis of clinical trials.

Methods

Data were extracted from studies that included placebo or inactive control groups, and the analysis was conducted using Comprehensive Meta‐Analysis (CMA) V4 software.

Results

Our findings indicate that monacolin K‐containing supplements are effective in lowering lipid levels, particularly low‐density lipoprotein cholesterol (LDL‐C).

Conclusion

These results highlight the potential of monacolin K as a promising adjunct therapy for hypercholesterolemia management, especially for patients who have not achieved LDL‐C targets with standard care or are intolerant to or unwilling to use statin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsLovastatinLipidsHypercholesterolemiaAnticholesteremic AgentsDyslipidemiasHumansRandomized Controlled Trials as TopicCholesterol, LDL

Stichwörter der Autor:innen

dyslipidemialipid profilemonacolin Knatural productsplasma lipid levelsstatin therapy

Substanzen

LovastatinLipidsCholesterol, LDLAnticholesteremic Agents

Autor:innen und Institutionen

  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, Turkey.
  • Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, India.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, India.

ORCID-Profile: Tannaz Jamialahmadi, Sercan Karav, Prashant Kesharwani, Amirhossein Sahebkar

Zitieren

APA

Jamialahmadi, T., Mirhadi, E., Karav, S., Kesharwani, P., & Sahebkar, A. (2026). Impact of Monacolin K‐Containing Supplements on Lipid Profile: A Meta‐Analysis of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70166

Vancouver

Jamialahmadi T, Mirhadi E, Karav S, Kesharwani P, Sahebkar A. Impact of Monacolin K‐Containing Supplements on Lipid Profile: A Meta‐Analysis of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism. 2026. doi:10.1002/edm2.70166

BibTeX
@article{Jamialahmadi2026,
  author = {Jamialahmadi, Tannaz and Mirhadi, Elaheh and Karav, Sercan and Kesharwani, Prashant and Sahebkar, Amirhossein},
  title = {Impact of Monacolin K‐Containing Supplements on Lipid Profile: A Meta‐Analysis of Randomised Controlled Trials},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  doi = {10.1002/edm2.70166}
}
Kostenlos starten →